Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Jill Wechsler

Washington Editor

Jill Wechsler is Pharmaceutical Technology's Washington editor. She can be contacted by postal mail at 7715 Rocton Ave., Chevy Chase, MD 20815, by telephone at 301.656.4634, or by e-mail at

FDA and Manufacturers Seek a More Secure Drug Supply Chain
April 2, 2014

New identifiers and tracking requirements aim to block illegitimate products.

Manufacturers Struggle with Breakthrough Drug Development
March 2, 2014

Accelerated testing and production create challenges in documenting product quality.

FDA Focuses on Drug Appearance and Attributes
February 2, 2014

FDA urges manufacturers to examine how shape, size, and color may affect patient safety and enhance treatment adherence.

Metrics Sought to Ensure Drug Quality
January 2, 2014

Regulators work with manufacturers to improve systems for measuring product performance and manufacturing reliability.

Analyzing Nano Drugs
December 12, 2013

FDA details efforts to evaluate potential risks from use of nanomaterials in drug products and discuss analytical considerations, impact on stability, safety, and toxicology effects.

Super Oversight for Generics
December 12, 2013

OGD is under pressure to improve review operations.

Congress Revises Rules for Drug Compounding and Supply-Chain Security
December 4, 2013

Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking.

Opioid Regulation Challenges FDA and Manufacturers
December 2, 2013

New policies and products seek to maintain access to pain medicines while curbing rampant abuse.

FDA Seeks Metrics to Define Drug Quality
November 13, 2013

Manufacturing standards are considered key to preventing drug recalls and shortages.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here